JP2023526311A5 - - Google Patents

Info

Publication number
JP2023526311A5
JP2023526311A5 JP2022569267A JP2022569267A JP2023526311A5 JP 2023526311 A5 JP2023526311 A5 JP 2023526311A5 JP 2022569267 A JP2022569267 A JP 2022569267A JP 2022569267 A JP2022569267 A JP 2022569267A JP 2023526311 A5 JP2023526311 A5 JP 2023526311A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
patient
brain mass
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022569267A
Other languages
English (en)
Japanese (ja)
Other versions
JP7832898B2 (ja
JP2023526311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031802 external-priority patent/WO2021231443A1/en
Publication of JP2023526311A publication Critical patent/JP2023526311A/ja
Publication of JP2023526311A5 publication Critical patent/JP2023526311A5/ja
Application granted granted Critical
Publication of JP7832898B2 publication Critical patent/JP7832898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022569267A 2020-05-12 2021-05-11 クラッベ病の治療に有用な組成物 Active JP7832898B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063023459P 2020-05-12 2020-05-12
US63/023,459 2020-05-12
US202063070653P 2020-08-26 2020-08-26
US63/070,653 2020-08-26
US202063073756P 2020-09-02 2020-09-02
US63/073,756 2020-09-02
PCT/US2021/031802 WO2021231443A1 (en) 2020-05-12 2021-05-11 Compositions useful in treatment of krabbe disease

Publications (3)

Publication Number Publication Date
JP2023526311A JP2023526311A (ja) 2023-06-21
JP2023526311A5 true JP2023526311A5 (cg-RX-API-DMAC7.html) 2024-05-22
JP7832898B2 JP7832898B2 (ja) 2026-03-18

Family

ID=76284168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569267A Active JP7832898B2 (ja) 2020-05-12 2021-05-11 クラッベ病の治療に有用な組成物

Country Status (12)

Country Link
US (1) US20230210941A1 (cg-RX-API-DMAC7.html)
EP (1) EP4149564A1 (cg-RX-API-DMAC7.html)
JP (1) JP7832898B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230023637A (cg-RX-API-DMAC7.html)
CN (1) CN116057175A (cg-RX-API-DMAC7.html)
AU (1) AU2021271635A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022021786A2 (cg-RX-API-DMAC7.html)
CA (1) CA3177924A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022017953A2 (cg-RX-API-DMAC7.html)
IL (1) IL298137A (cg-RX-API-DMAC7.html)
MX (1) MX2022014245A (cg-RX-API-DMAC7.html)
WO (1) WO2021231443A1 (cg-RX-API-DMAC7.html)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1967872A (en) 1930-07-14 1934-07-24 Gilbert E Doan Welding electrode
JP2002521107A (ja) 1998-07-23 2002-07-16 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 高解像度画像センサを備えたx線検査装置
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
US8005620B2 (en) 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
WO2005012877A2 (en) 2003-08-01 2005-02-10 Dna Twopointo Inc. Systems and methods for antibody engineering
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
WO2011126808A2 (en) 2010-03-29 2011-10-13 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
EP2588132A4 (en) * 2010-06-25 2014-10-15 Shire Human Genetic Therapies METHOD AND COMPOSITIONS FOR DELIVERING BETA GALACTOCEREBROSIDASE INTO THE CNS
FR2977562B1 (fr) 2011-07-06 2016-12-23 Gaztransport Et Technigaz Cuve etanche et thermiquement isolante integree dans une structure porteuse
US9719106B2 (en) * 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
WO2016049230A1 (en) 2014-09-24 2016-03-31 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
IL262207B2 (en) 2016-04-15 2026-01-01 Univ Pennsylvania Preparations for the treatment of wet age-related macular degeneration
JP2020505317A (ja) 2017-01-20 2020-02-20 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 臍帯血移植(ucbt)および増加したガラクトセレブロシダーゼの発現によるクラッベ病の処置
RS65241B1 (sr) 2017-02-28 2024-03-29 Univ Pennsylvania Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
WO2018160852A1 (en) 2017-03-03 2018-09-07 Cook Medical Technologies, LLC Rapid exchange multiple catheter system
EP3692158A4 (en) * 2017-10-03 2021-08-04 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMAL DISEASES
EP3860714B1 (en) 2018-10-03 2023-09-06 Siteone Therapeutics, Inc. 11,13-modified saxitoxins for the treatment of pain
EP3931337A1 (en) * 2019-02-26 2022-01-05 The Trustees of The University of Pennsylvania Compositions useful in treatment of krabbe disease

Similar Documents

Publication Publication Date Title
JP7860176B2 (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
TWI832036B (zh) 用於aav之遞送之組合物及方法
US20220175887A1 (en) Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus
JP2021500029A (ja) Nt−3遺伝子治療のための方法及び材料
JP2025060641A (ja) Aavウイルスベクター及びその使用
JP2022511776A5 (cg-RX-API-DMAC7.html)
JP2021523198A5 (cg-RX-API-DMAC7.html)
TW201629225A (zh) 第九因子基因療法
JP2023540054A5 (cg-RX-API-DMAC7.html)
CN110325219B (zh) 编码甲基-CpG结合蛋白2的重组腺相关病毒的鞘内递送
JP2022523766A5 (cg-RX-API-DMAC7.html)
JP2022512589A5 (cg-RX-API-DMAC7.html)
JP2025506383A5 (cg-RX-API-DMAC7.html)
JP2021534154A5 (cg-RX-API-DMAC7.html)
US20200318080A1 (en) Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus
CA3178591A1 (en) Immunosuppressive agents and viral delivery re-dosing methods for gene therapy
CN119255814A (zh) 脑中bag3和蛋白质的质量控制
JP2023513487A5 (cg-RX-API-DMAC7.html)
JP2022525848A5 (cg-RX-API-DMAC7.html)
AU2022325237A2 (en) Retrograde coronary venous or sinus administration of therapeutics
JP2022550954A5 (cg-RX-API-DMAC7.html)
JP2022518354A5 (cg-RX-API-DMAC7.html)
JP2022522004A (ja) 依存症障害の遺伝子治療
RU2796274C2 (ru) Вирусные векторы на основе aav и пути их применения
HK40121244A (en) Methods and materials for nt-3 gene therapy